share_log

Ardelyx | 4: Statement of changes in beneficial ownership of securities-Officer Williams Laura A

Ardelyx | 4：持股變動聲明-高管 Williams Laura A

SEC announcement ·  02/22 16:58
Moomoo AI 已提取核心訊息
Ardelyx, Inc.'s Chief Medical Officer, Laura A. Williams, completed a sale of company stock on February 20, 2024. The transaction involved 4,803 shares of Ardelyx common stock at a price of $8.7463 per share, resulting in a total sale value of $42,008.48. Following the sale, Williams holds a total of 380,138 Ardelyx shares directly. The sale was conducted in the open market.
Ardelyx, Inc.'s Chief Medical Officer, Laura A. Williams, completed a sale of company stock on February 20, 2024. The transaction involved 4,803 shares of Ardelyx common stock at a price of $8.7463 per share, resulting in a total sale value of $42,008.48. Following the sale, Williams holds a total of 380,138 Ardelyx shares directly. The sale was conducted in the open market.
Ardelyx, Inc. '的首席醫療官勞拉·威廉姆斯於2024年2月20日完成了公司股票的出售。該交易涉及4,803股Ardelyx普通股，價格爲每股8.7463美元，總銷售價值爲42,008.48美元。出售後，威廉姆斯直接持有總計380,138股Ardelyx股票。此次出售是在公開市場上進行的。
Ardelyx, Inc. '的首席醫療官勞拉·威廉姆斯於2024年2月20日完成了公司股票的出售。該交易涉及4,803股Ardelyx普通股，價格爲每股8.7463美元，總銷售價值爲42,008.48美元。出售後，威廉姆斯直接持有總計380,138股Ardelyx股票。此次出售是在公開市場上進行的。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息